Emerging molecular biomarkers--blood-based strategies to detect and monitor cancer.
about
Discovery and validation of new potential biomarkers for early detection of colon cancerDirect detection of alternative open reading frames translation products in human significantly expands the proteomePotential Role of MicroRNA-210 as Biomarker in Human Cancers Detection: A Meta-AnalysisMass spectrometry in cancer biomarker research: a case for immunodepletion of abundant blood-derived proteins from clinical tissue specimensThe effect of pre-analytical variability on the measurement of MRM-MS-based mid- to high-abundance plasma protein biomarkers and a panel of cytokinesHarnessing pain heterogeneity and RNA transcriptome to identify blood-based pain biomarkers: a novel correlational study design and bioinformatics approach in a graded chronic constriction injury model.A blood-based proteomic classifier for the molecular characterization of pulmonary nodules.Improved blood tests for cancer screening: general or specific?Detection of aberrant promoter methylation of RNF180, DAPK1 and SFRP2 in plasma DNA of patients with gastric cancer.Universal disease biomarker: can a fixed set of blood microRNAs diagnose multiple diseases?Multiplexed electrochemical protein detection and translation to personalized cancer diagnosticsSerum proteomic profiling for the early diagnosis of colorectal cancer.Gene expression analysis of peripheral blood cells reveals Toll-like receptor pathway deregulation in colorectal cancerCirculating miRNA biomarkers for Alzheimer's diseaseSerum biomarkers reflecting specific tumor tissue remodeling processes are valuable diagnostic tools for lung cancer.Potential of soluble CD26 as a serum marker for colorectal cancer detection.Reproductive and hormonal risk factors for antinuclear antibodies (ANA) in a representative sample of U.S. womenValidation of a multiprotein plasma classifier to identify benign lung nodulesEvaluation and identification of microRNA-106 in the diagnosis of cancer: a meta-analysisMagnetic particles in ultrasensitive biomarker protein measurements for cancer detection and monitoring.The human circadian metabolome.Nanostructured immunosensor for attomolar detection of cancer biomarker interleukin-8 using massively labeled superparamagnetic particlesFabrication of immunosensor microwell arrays from gold compact discs for detection of cancer biomarker proteins.Plasma Autoantibodies Associated with Basal-like Breast Cancers.Detection of novel biomarkers for ovarian cancer with an optical nanotechnology detection system enabling label-free diagnostics.Sensitive and direct detection of circulating tumor cells by multimarker µ-nuclear magnetic resonance.Exogenous marker-engineered mesenchymal stem cells detect cancer and metastases in a simple blood assay.Analysis of serum total and free PSA using immunoaffinity depletion coupled to SRM: correlation with clinical immunoassay tests.Sox17 promoter methylation in plasma DNA is associated with poor survival and can be used as a prognostic factor in breast cancer.Highly efficient binding of paramagnetic beads bioconjugated with 100,000 or more antibodies to protein-coated surfaces.Integrative DNA methylome analysis of pan-cancer biomarkers in cancer discordant monozygotic twin-pairsQuantification of the N-glycosylated secretome by super-SILAC during breast cancer progression and in human blood samples.Biomarkers intersect with the exposomeEvaluation of Plasma miR-21 and miR-152 as Diagnostic Biomarkers for Common Types of Human CancersIdentification of potential glycan cancer markers with sialic acid attached to sialic acid and up-regulated fucosylated galactose structures in epidermal growth factor receptor secreted from A431 cell line.Gold nanoparticle-based activatable probe for sensing ultralow levels of prostate-specific antigen.Potential role of microRNA-126 in the diagnosis of cancers: A systematic review and meta-analysisHOTAIRM1 as a potential biomarker for diagnosis of colorectal cancer functions the role in the tumour suppressor.Serum DNA methylation for monitoring response to neoadjuvant chemotherapy in breast cancer patients.Detection of cell carcinogenic transformation by a quadruplex DNA binding fluorescent probe
P2860
Q21131953-CDDA6CB9-18EF-4B5B-BED1-CB842B3FE5F9Q21132658-A7A7A5AB-ADB6-405E-A392-CA0CFF730756Q26786404-74FE02F7-EA27-4814-8DDF-BCB6913F7936Q28307595-846585E0-BEA3-4930-85F2-89CBC5DA1C64Q28484137-C9E4DB32-EA0B-43A5-B8F1-F4E58DEE8A7EQ33919488-888CB6EE-0B3A-4D10-945A-0551B4613608Q33968948-ADC803E7-3D85-45DF-987E-00D3161CD3E4Q34086617-38426CB9-77C9-46B2-9D49-E2D5D4398A94Q34141405-A6DB2FAA-2296-4636-A6AF-E6CB252CECDCQ34168908-BAF9C490-A9B7-4F59-8F2A-0DA1D8973A4AQ34342253-1EB86139-5A9F-42B6-B4D3-358035D6B410Q34409534-694F791D-972E-4F1A-A34C-862F87C7AB41Q34708456-29E2B938-D7DC-45D6-A3CA-C45FFDB3CDEBQ34904013-9F9D0AC4-1940-4E22-BB7A-4F7B7EF96DD1Q34998455-93AE966B-B04B-4A5C-8D61-893696B7EC04Q35113393-73581CBF-70AE-4614-AA57-EB06155D06FEQ35183153-15FD3504-4AC3-4A3A-BCAC-99DDD6469B07Q35241794-1F5EDB5B-8A81-45F8-9B05-FFE57595E5E5Q35445305-E7D373E7-2C39-4FE4-AEC6-5B4A4362EDA5Q35549676-D9C91D34-B8EA-4BB7-AEAB-4D1BF8CC26BDQ35786923-A900D347-3A3E-4C18-BDF0-2241846C557FQ35859820-E55B4203-8D1A-4C43-9F8C-B677F305333AQ35895579-E4BECAB5-8D7A-43F6-A148-7FFDFE0C5224Q36029610-9275AD5A-6D12-411F-868A-323627AB6A0BQ36052066-E58FF1A1-F706-4CCE-9195-268DC69F809AQ36062143-46F7D4CA-13A5-4E7E-A1FD-0D409A1B154EQ36082553-BBE9A4E5-77B0-4617-B8BD-D0B3AD002BB1Q36136098-A224B559-3533-4DCA-8218-70CD4CB5D0CCQ36151111-470B47BE-7D8D-42E4-AA4C-2E0536FB0DD9Q36445836-4E16BEE2-331D-428C-BC49-824E5C796FBFQ36485634-D749AC9A-3830-40D1-A551-B603240DD612Q36508121-496A6B2C-E9C7-40C3-862E-DE50B84E8393Q36607005-7A73EC70-35F7-4B7D-800D-933F4A7E76BEQ36657311-E52C9CDD-B4A3-412C-A650-7B4F12600357Q36832476-ACAA3F10-C045-4647-93FF-C85A01BD2266Q36966723-73E428E9-45F9-41D6-8E01-C1D7C8985157Q37226272-672DAC1D-23F2-4589-AA68-C02E7A0DA679Q37370795-00D66BB9-6BC8-4C74-A104-2DFBAD00DE00Q37522662-06B59851-D86D-4363-B032-A6FBAD675653Q37525196-5EC1B7F4-B551-4DCD-9A0B-61A3F4F05992
P2860
Emerging molecular biomarkers--blood-based strategies to detect and monitor cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Emerging molecular biomarkers--blood-based strategies to detect and monitor cancer.
@en
Emerging molecular biomarkers--blood-based strategies to detect and monitor cancer.
@nl
type
label
Emerging molecular biomarkers--blood-based strategies to detect and monitor cancer.
@en
Emerging molecular biomarkers--blood-based strategies to detect and monitor cancer.
@nl
prefLabel
Emerging molecular biomarkers--blood-based strategies to detect and monitor cancer.
@en
Emerging molecular biomarkers--blood-based strategies to detect and monitor cancer.
@nl
P2860
P1476
Emerging molecular biomarkers--blood-based strategies to detect and monitor cancer.
@en
P2093
Christina S Baik
Samir M Hanash
P2860
P304
P356
10.1038/NRCLINONC.2010.220
P407
P577
2011-03-01T00:00:00Z